3
2
1

Wiring Electrodes to Transplanted "Mini-Brains": Targeted Brain Stimulation Teaches Neurons to Process Vision

Release time:

2026-11-17

Transplanting human brain organoids grown in the lab into damaged brain tissue is a direction long awaited in neural repair. But what has long troubled researchers is that transplanted neurons often operate "on their own" from host circuits — integrating chaotically and failing to truly reconnect the damaged neural microcircuitry. Recently, a team led by Xiao-Hong Li at Tianjin University published a study in Cell Stem Cell proposing an "instructive neural interface" strategy: using the host's own brain rhythms as a template to direct the regulation of transplanted neurons, so that they acquire layer-4 (L4) cortical functional properties and improve visual behavior in mice. The paper was published online on November 6.

First connect them, then train them to work. Using adult immunodeficient mice as the model, the team created a ~1-millimeter lesion cavity in the primary visual cortex (V1) via vacuum aspiration, then transplanted human brain organoids cultured for 40 days in vitro. Sixty days after transplantation, the team performed a second craniotomy to implant flexible dual-shank electrodes (32 channels per shank): one shank inserted into the organoid, the other into the lateral geniculate nucleus (LGN), the relay station of visual information — allowing real-time reading of electrical activity on both sides.

 

Stimulation came in two phases. In the first phase, uniform electrical stimulation (70 Hz, 50 microamps) was applied across 5 sites for 8 days, aiming to promote broad coupling between graft and host. After a two-week interval, the second phase applied same-frequency rhythmic stimulation for 8 days — but only to the 5 adjacent channels with the highest narrowband gamma (NBG, ~60 Hz) power. To rule out confounds, the team set up multiple control groups: random-interval stimulation, 20 Hz stimulation, and 60 Hz stimulation applied to regions of low NBG power.

 

Both frequency and location matter — neither alone suffices. The results showed that only "the right location plus the right frequency" worked: in the targeted group, NBG power and phase-locking values rose significantly, and the phase difference between graft firing and host rhythms narrowed — none of the three controls showed these effects. More crucially, at the functional level: the proportion of direction-selective neurons and the direction selectivity index increased significantly in the targeted group, and the effect dropped significantly when visual input was masked — showing that these neurons were indeed receiving and processing visual information.

 

Behavioral validation was performed 5 months after transplantation: in the visual water maze test, the targeted group's visual acuity (spatial frequency threshold) and contrast sensitivity were significantly better than both the unstimulated group and the non-targeted stimulation group. Morphologically, the targeted group showed increased inhibitory and excitatory synaptic markers and dendritic spine density; tracing experiments confirmed bidirectional connections between the graft and the LGN. Single-nucleus RNA sequencing further revealed a significant increase in NECAB1⁺ glutamatergic neurons (an L4 marker) in the targeted group — the authors specifically noted that "L4-competent" refers to acquiring L4-typical molecular and functional properties, not rebuilding the anatomical laminar structure.

 

From "cell replacement" to "instructed assembly."​ The significance of this work lies in a paradigm shift: organoid transplantation had mostly pinned hopes on spontaneous cell integration, but this study demonstrates that exogenous rhythmic stimulation can actively "instruct" the circuit assembly of grafts — and it identifies days 60–90 post-transplantation as the key plasticity window. The authors also list limitations: the vacuum aspiration model cannot fully reproduce the complex pathology of clinical brain trauma or stroke; electrode density limits spatial resolution; and long-term safety (no tumors observed over 4 months) still requires validation over longer periods.

Latest developments

【The YinFeng Life Continuation Project Debuts at the 2026 Annual Meeting of the Chinese Medical Association's Medical Ethics Branch—Ethics Leading Biotech Toward Benevolent Innovation】

The debut and discourse of the YinFeng Life Continuation Project not only served as an authoritative demonstration of its own ethical governance framework but also contributed practical wisdom toward establishing industry norms.

Yinfeng Foundation Honored as "2025 Public Welfare Donor" by Jinan Red Cross

Looking ahead, Yinfeng Foundation will use this recognition as an opportunity to further deepen its strategic collaboration with the Jinan Red Cross, expand cooperation in areas such as life health and emergency response, and continue to empower efforts to accelerate the construction of a "new, strong, excellent, rich, beautiful, and high-quality" modern socialist strong capital city, contributing even more Yinfeng strength to this endeavor.

Yinfeng Life Science Research Institute, in Collaboration with University of Science and Technology of China, Develops CryoSIM Platform, Published in Top Analytical Chemistry Journal Revolutionizing Oocyte Membrane Permeability Analysis Technology

The team successfully developed the CryoSIM platform, an intelligent microfluidics and deep learning-integrated system. This platform deeply integrates core technologies of deep learning and microfluidics to enable high-throughput, high-precision automated analysis of oocyte membrane permeability. It provides a novel technological tool for optimizing and advancing the clinical translation of oocyte cryopreservation techniques. Additionally, it offers an innovative practical paradigm for the application of artificial intelligence in low-temperature biomedicine and reproductive medicine.

Public Welfare Partnership: A Special Letter from the Jinan Red Cross

On the afternoon of January 30, 2026, the Jinan Red Cross presented a letter of special significance to the Shandong Yinfeng Life Science Public Welfare Foundation (hereinafter referred to as the Yinfeng Foundation).

World’s First Achievement Highlights Brand Leadership

In the future, Yinfeng Life Science Research Institute will continue to uphold its mission of "Dedicated to Medical Technology, Safeguarding Human Health." It will empower brand building with more original and pioneering scientific and technological achievements, contributing wisdom and strength to Shandong's goal of building a national regional innovation hub and promoting Chinese brands on the global stage.

Global First Ovarian Tissue Dual Activation Technology Debuts at 2025 Jinan Achievements Conference

Currently, the ovarian tissue dual activation technology has been successfully applied in clinical practice at Beijing University of Chinese Medicine Shenzhen (Longgang) Hospital, having treated over 400 patients with a treatment success rate of 70%. Over the next three years, Shandong Yinfeng Life Science Research Institute plans to use Jinan as a center to gradually expand the transformation and application of this technological achievement nationwide.